Low SP1 Expression Differentially Affects Intestinal-Type Compared with Diffuse-Type Gastric Adenocarcinoma

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Lee, Hun Seok ^a   Park, Cheol Keun ^b   Oh, Ensel ^a   Erkin, Özgür Cem ^a   Jung, Hun Soon ^a   Cho, Mi Hyun ^a   Kwon, Mi Jeong ^c   Chae, Seoung Wan ^d   Kim, Seok Hyung ^b   Wang, Li Hui ^e   Park, Min Jeong ^a   Lee, Su Yeon ^a   Yang, Ho Bin ^a   Jia, Lina ^e   Choi, Yoon La ^b   Shin, Young Kee ^a  

^a Seoul National University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Kyungpook National University   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SP1;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DIFFUSE TYPE GASTRIC ADENOCARCINOMA; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINAL TYPE GASTRIC ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; WESTERN BLOTTING;

ADENOCARCINOMA; AGED; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; SP1 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TRANSFECTION;

EID: 84874273242     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055522     Document Type: Article

References (33)

1. Roukos DH, Agnantis NJ, Fatouros M, Kappas AM, (2002) (Mini-Review) Gastric Cancer: Introduction, Pathology, Epidemiology. Gastric Breast Cancer 1: 1-3.
2. Crew KD, Neugut AI, (2006) Epidemiology of gastric cancer. World J Gastroenterol 12: 354-362.
3. Lauren P, (1965) The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called Intestinal-Type Carcinoma. An Attempt at a Histo-Clinical Classification. Acta Pathol Microbiol Scand 64: 31-49.
4. Suske G, (1999) The Sp-family of transcription factors. Gene 238: 291-300.
5. Wright C, Angus B, Napier J, Wetherall M, Udagawa Y, et al. (1987) Prognostic factors in breast cancer: immunohistochemical staining for SP1 and NCRC 11 related to survival, tumour epidermal growth factor receptor and oestrogen receptor status. J Pathol 153: 325-331.
6. Shi Q, Le X, Abbruzzese JL, Peng Z, Qian CN, et al. (2001) Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res 61: 4143-4154.
7. Wang L, Wei D, Huang S, Peng Z, Le X, et al. (2003) Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 9: 6371-6380.
8. Yao JC, Wang L, Wei D, Gong W, Hassan M, et al. (2004) Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res 10: 4109-4117.
9. Zhang J, Zhu ZG, Ji J, Yuan F, Yu YY, et al. (2005) Transcription factor Sp1 expression in gastric cancer and its relationship to long-term prognosis. World J Gastroenterol 11: 2213-2217.
10. Lee JH, Kim SH, Wang LH, Choi YL, Kim YC, et al. (2007) Clinical significance of CD99 down-regulation in gastric adenocarcinoma. Clin Cancer Res 13: 2584-2591.
11. Wang LH, Kim SH, Lee JH, Choi YL, Kim YC, et al. (2007) Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression. Clin Cancer Res 13: 102-110.
12. Kwon MJ, Oh E, Lee S, Roh MR, Kim SE, et al. (2009) Identification of novel reference genes using multiplatform expression data and their validation for quantitative gene expression analysis. PLoS One 4: e6162.
13. Hay R, Park J-G, Gazdar AF (1994) Atlas of human tumor cell lines. San Diego: Academic Press. xii, 486 p.
14. Deniaud E, Baguet J, Mathieu AL, Pages G, Marvel J, et al. (2006) Overexpression of Sp1 transcription factor induces apoptosis. Oncogene 25: 7096-7105.
15. Safe S, Abdelrahim M, (2005) Sp transcription factor family and its role in cancer. Eur J Cancer 41: 2438-2448.
16. Sankpal UT, Goodison S, Abdelrahim M, Basha R, (2011) Targeting Sp1 transcription factors in prostate cancer therapy. Med Chem 7: 518-525.
17. Wang L, Guan X, Gong W, Yao J, Peng Z, et al. (2005) Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer. Clin Exp Metastasis 22: 205-213.
18. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB, (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93: 9821-9826.
19. Takeichi M, (1993) Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 5: 806-811.
20. Birchmeier W, Behrens J, Weidner KM, Hulsken J, Birchmeier C, (1996) Epithelial differentiation and the control of metastasis in carcinomas. Curr Top Microbiol Immunol 213 (Pt 2): 117-135.
21. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, et al. (1993) E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 53: 1690-1695.
22. Becker KF, Keller G, Hoefler H, (2000) The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol 9: 5-11.
23. Tahara E (2004) Genetic pathways of two types of gastric cancer. IARC Sci Publ: 327-349.
24. Campanella GSV, Colvin RA, Luster AD (2010) CXCL10 Can Inhibit Endothelial Cell Proliferation Independently of CXCR3. PLoS One 5:-.
25. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, et al. (2002) Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21: 1743-1753.
26. Lamouille S, Mallet C, Feige JJ, Bailly S, (2002) Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100: 4495-4501.
27. Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ, (1995) Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 15: 2672-2681.
28. Jutooru I, Chadalapaka G, Lei P, Safe S, (2010) Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation. J Biol Chem 285: 25332-25344.
29. Chadalapaka G, Jutooru I, Burghardt R, Safe S, (2010) Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells. Mol Cancer Res 8: 739-750.
30. Abdelrahim M, Baker CH, Abbruzzese JL, Sheikh-Hamad D, Liu S, et al. (2007) Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells. Cancer Res 67: 3286-3294.
31. Black AR, Black JD, Azizkhan-Clifford J, (2001) Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188: 143-160.
32. Sheibani N, Scheef EA, Dimaio TA, Wang Y, Kondo S, et al. (2007) Bcl-2 expression modulates cell adhesion and migration promoting branching of ureteric bud cells. J Cell Physiol 210: 616-625.
33. Sung HY, Guan H, Czibula A, King AR, Eder K, et al. (2007) Human tribbles-1 controls proliferation and chemotaxis of smooth muscle cells via MAPK signaling pathways. J Biol Chem 282: 18379-18387.